Mary E. Klotman's most recent trade in AMGEN Inc. was a trade of 809 Common Stock done . Disclosure was reported to the exchange on May 23, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
AMGEN Inc | Mary E. Klotman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2025 | 809 | 1,528 (0%) | 0% | 0 | Common Stock | |
AMGEN Inc | Mary E. Klotman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 719 | 719 (0%) | 0% | 0 | Common Stock |